186 related articles for article (PubMed ID: 18278547)
1. Serum pro-hepcidin levels in rheumatoid arthritis and systemic lupus erythematosus.
Koca SS; Isik A; Ustundag B; Metin K; Aksoy K
Inflammation; 2008 Jun; 31(3):146-53. PubMed ID: 18278547
[TBL] [Abstract][Full Text] [Related]
2. Serum pro-hepcidin could reflect disease activity in patients with rheumatoid arthritis.
Kim HR; Kim KW; Yoon SY; Kim SH; Lee SH
J Korean Med Sci; 2010 Mar; 25(3):348-52. PubMed ID: 20191031
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients.
Song SN; Iwahashi M; Tomosugi N; Uno K; Yamana J; Yamana S; Isobe T; Ito H; Kawabata H; Yoshizaki K
Arthritis Res Ther; 2013 Oct; 15(5):R141. PubMed ID: 24286116
[TBL] [Abstract][Full Text] [Related]
4. Serum prohepcidin concentrations in rheumatoid arthritis.
Jayaranee S; Sthaneshwar P; Sokkalingam S
Pathology; 2009 Feb; 41(2):178-82. PubMed ID: 18972320
[TBL] [Abstract][Full Text] [Related]
5. Etanercept improved anemia and decreased hepcidin gene expression in a rat model of rheumatoid arthritis.
Elsheemy MS; Hasanin AH; Mansour A; Mehrez SI; Abdel-Bary M
Biomed Pharmacother; 2019 Apr; 112():108740. PubMed ID: 30970527
[TBL] [Abstract][Full Text] [Related]
6. Rheumatoid anemia.
Masson C
Joint Bone Spine; 2011 Mar; 78(2):131-7. PubMed ID: 20851655
[TBL] [Abstract][Full Text] [Related]
7. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
[TBL] [Abstract][Full Text] [Related]
8. Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis.
Abdel-Khalek MA; El-Barbary AM; Essa SA; Ghobashi AS
J Rheumatol; 2011 Oct; 38(10):2153-9. PubMed ID: 21885483
[TBL] [Abstract][Full Text] [Related]
9. Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial.
Doyle MK; Rahman MU; Frederick B; Birbara CA; de Vries D; Toedter G; Wu X; Chen D; Ranganath VK; Westerman ME; Furst DE
Rheumatology (Oxford); 2013 Jul; 52(7):1214-9. PubMed ID: 23418046
[TBL] [Abstract][Full Text] [Related]
10. Circulating hepcidin in the crossroads of anemia and inflammation associated with rheumatoid arthritis.
Demirag MD; Haznedaroglu S; Sancak B; Konca C; Gulbahar O; Ozturk MA; Goker B
Intern Med; 2009; 48(6):421-6. PubMed ID: 19293540
[TBL] [Abstract][Full Text] [Related]
11. [Concentrations of pro-hepcidin in serum of pregnant women and in umbilical cord blood].
Chełchowska M; Swiatek E; Ambroszkiewicz J; Gajewska J; Laskowska-Klita T; Leibschang J
Ginekol Pol; 2008 Nov; 79(11):754-7. PubMed ID: 19140497
[TBL] [Abstract][Full Text] [Related]
12. Iron regulatory hormone hepcidin decreases in chronic heart failure patients with anemia.
Matsumoto M; Tsujino T; Lee-Kawabata M; Naito Y; Akahori H; Sakoda T; Ohyanagi M; Tomosugi N; Masuyama T
Circ J; 2010 Feb; 74(2):301-6. PubMed ID: 20019408
[TBL] [Abstract][Full Text] [Related]
13. The interleukin-6-hepcidin-hemoglobin circuit in systemic lupus erythematosus flares.
Indrakanti DL; Alvarado A; Zhang X; Birmingham DJ; Hinton A; Rovin BH
Lupus; 2017 Feb; 26(2):200-203. PubMed ID: 27416847
[TBL] [Abstract][Full Text] [Related]
14. Serum prohepcidin is associated with soluble transferrin receptor-1 but not ferritin in healthy post-menopausal women.
Huang X; Fung ET; Yip C; Zeleniuch-Jacquotte A
Blood Cells Mol Dis; 2008; 41(3):265-9. PubMed ID: 18694648
[TBL] [Abstract][Full Text] [Related]
15. The relationship between serum ferritin levels and disease activity in systemic lupus erythematosus.
Beyan E; Beyan C; Demirezer A; Ertuğrul E; Uzuner A
Scand J Rheumatol; 2003; 32(4):225-8. PubMed ID: 14626629
[TBL] [Abstract][Full Text] [Related]
16. Serum ferritin as a serologic marker of activity in systemic lupus erythematosus.
Lim MK; Lee CK; Ju YS; Cho YS; Lee MS; Yoo B; Moon HB
Rheumatol Int; 2001 Apr; 20(3):89-93. PubMed ID: 11354563
[TBL] [Abstract][Full Text] [Related]
17. Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis.
Sato H; Takai C; Kazama JJ; Wakamatsu A; Hasegawa E; Kobayashi D; Kondo N; Nakatsue T; Abe A; Ito S; Ishikawa H; Kuroda T; Suzuki Y; Narita I
Sci Rep; 2020 Jun; 10(1):9882. PubMed ID: 32555299
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
[TBL] [Abstract][Full Text] [Related]
19. Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease.
Kuo HC; Yang YL; Chuang JH; Tiao MM; Yu HR; Huang LT; Yang KD; Chang WC; Lee CP; Huang YH
J Clin Immunol; 2012 Aug; 32(4):746-52. PubMed ID: 22392047
[TBL] [Abstract][Full Text] [Related]
20. Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis.
Arnold J; Sangwaiya A; Bhatkal B; Geoghegan F; Busbridge M
Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):425-9. PubMed ID: 19262400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
